What ails Indian pharmaceutical space? Here's what CCI says

Cardiac medicines accounted for the highest volumes in 2020. Despite the burden of diabetes rising, its share in volumes was low; however, its share in total value was higher

The pharmaceutical industry's turnover in India increased 165 times from Rs 1,750 crore in 1990 to Rs 2.89 trillion in 2020. The total share of domestic sales was Rs 1.41 trillion.

Spending on pharmaceutical products accounts for over a fourth of total health spending in the country. Its share in out-of-pocket expenditure on health was 43.2 per cent, and 97 per cent of it was spent on generics—formulations that are not under any patent.

It is not surprising then that the Competition Commission of India's study focuses on the impact of generics in the Indian market and the fault in